Antimuscarinics for treatment of overactive bladder
Top Cited Papers
- 1 January 2004
- journal article
- review article
- Published by Elsevier
- Vol. 3 (1) , 46-53
- https://doi.org/10.1016/s1474-4422(03)00622-7
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- The standardisation of terminology of lower urinary tract function: Report from the standardisation sub‐committee of the International Continence SocietyNeurourology and Urodynamics, 2002
- Effects of Tolterodine, Trospium Chloride, and Oxybutynin on the Central Nervous SystemThe Journal of Clinical Pharmacology, 2001
- TolterodineDrugs & Aging, 2001
- Antimuscarinic Potency and Bladder Selectivity of PNU‐200577, a Major Metabolite of TolterodineBasic & Clinical Pharmacology & Toxicology, 1997
- Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivoBritish Journal of Pharmacology, 1997
- Discovery & development of selective M3 antagonists for clinical useLife Sciences, 1997
- Tolterodine-a new bladder selective muscarinic receptor antagonist: Preclinical pharmacological and clinical dataLife Sciences, 1997
- Evidence for inhibitory nicotinic and facilitatory muscarinic receptors in cholinergic nerve terminals of the rat urinary bladderJournal of the Autonomic Nervous System, 1992
- Current Concepts in the Treatment of Disorders of MicturitionDrugs, 1988
- The Effect of Ubretid on Bladder Function after Recent Complete Spinal Cord InjuryBritish Journal of Urology, 1974